Fundraising Fox

Kypha

St. Louis, US · Delaware corporation · 3 known investors

kypha.net ↗

Kypha develops clinical diagnostic tests for immune system biomarkers, particularly complement activity markers, and provides solutions for real-time immune insights across therapeutic areas. The company serves biopharma firms, clinical laboratories, and medical institutions through a network of clinical collaborators and research partners.

BiotechDeep TechHealthtechMedical Devicesin /kypha-inc.

Founders & leadership

NS
Nick StatenExecutive Officer
TS
T. Scott GloverExecutive Officer
JD
James D. MarselisDirector
PR
Peter ReineckeDirector
JS
Jonathan SackierDirector
DS
David SmollerDirector
CS
Chad StieningDirector

Investors · 3

BioGenerator VenturesSt. Louis · $50K – $250K
Missouri Technology CorporationSt. Louis
Serra VenturesreportedChampaign · $5M

Reported raises · per SEC filings

Form D private placements
▶$5.2MraisedMay 2022 · 13 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Chad StieningExecutive Officer, Director
  • Gerhard BetteDirector
  • Dennert WareDirector
  • James MerselisDirector
  • Peter ReineckeDirector
Offering amount
$17M
Amount sold
$5.2M
Minimum investment
$1
First sale
Apr 2022
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$950KraisedJul 2018 · 1 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Peter ReineckeDirector
  • James MerselisDirector
  • Jonathan SackierDirector
  • Chad StieningExecutive Officer, Director
Offering amount
$950K
Amount sold
$950K
Minimum investment
$1
First sale
Jun 2018
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$5.5MraisedMay 2018 · 13 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • James MerselisDirector
  • Jonathan SackierDirector
  • Chad StieningExecutive Officer, Director
  • Peter ReineckeDirector
Offering amount
$7.9M
Amount sold
$5.5M
Minimum investment
$1
First sale
Apr 2018
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2.1MraisedNov 2015 · 3 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Nick StatenExecutive Officer
  • T. Scott GloverExecutive Officer
  • James D. MarselisDirector
  • Peter ReineckeDirector
  • Jonathan SackierDirector
  • David SmollerDirector
  • Chad StieningDirector
Offering amount
$3.2M
Amount sold
$2.1M
Minimum investment
$15K
First sale
Feb 2015
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news